Retractable Technologies (RVP) Research & Development (2010 - 2026)
Retractable Technologies' (RVP) quarterly Research & Development came in at $170416.0 in Q1 2026, down 10.87% YoY from $191192.0 in Q1 2025, and up 36.48% on a QoQ basis from $124864.0 in Q4 2025.
Retractable Technologies (RVP) Research & Development (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Research & Development data on file, last reported at $170416.0 in Q1 2026.
- Quarterly Research & Development fell 10.87% year-over-year to $170416.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 389.82% YoY) and the FY2025 annual result came in at $675567.0, changed 0.24% from the prior year.
- Research & Development grew to $170416.0 in Q1 2026, from $124864.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $5.3 million in Q4 2023 to a low of $95538.0 in Q1 2022.
- A 5-year average of $913867.2 and a median of $199093.0 in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development soared 1313.23% — and 2024, when it tumbled 97.01%.
- Tracing RVP's Research & Development over 5 years: stood at $1.3 million in 2022, then soared by 311.24% to $5.3 million in 2023, then plunged by 97.01% to $157894.0 in 2024, then dropped by 20.92% to $124864.0 in 2025, then soared by 36.48% to $170416.0 in 2026.
- The last three Research & Development figures came in at $170416.0 (Q1 2026), $124864.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.91 Bn | 129.69 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 52.53 Bn | 51.67 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.74 Bn | 34.39 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.94 Bn | 32.47 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 29.03 Bn | 26.35 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.94 Bn | 24.51 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.29 Bn | 14.89 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.64 Bn | 11.49 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Retractable Technologies | 21.41 Mn | -18.46 Mn | 190,852.00 | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,416.00 |
| Dec 31, 2025 | 124,864.00 |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 191,192.00 |
| Dec 31, 2024 | 157,894.00 |
| Sep 30, 2024 | 174,695.00 |
| Jun 30, 2024 | 199,093.00 |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 138,761.00 |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 105,749.00 |
| Jun 30, 2022 | 206,388.00 |
| Mar 31, 2022 | 95,538.00 |
| Dec 31, 2021 | 3.73 Mn |
| Sep 30, 2021 | 199,200.00 |
| Jun 30, 2021 | 399,042.00 |